MAPK Inhibitor Negative Control SB 202474

Catalog number: PHZ1143

Invitrogen™  Related applications: Mammalian Cell Culture | Pharma & Biopharma | Protein Assays and Analysis | Target & Lead Identification & Validation

Error loading your content!

  Catalog number
Select a plan
Unit size
Price ({{currency}}) Availability Qty
{{product.sku}} {{product.sku}} also known as {{product.formattedSku}} 
Pro add-ons

Your on-site stock

›› {{supplyCenter.scName}}({{scProduct.stockOnHand}} In stock)
›› {{supplyCenter.scName}}(Out of stock)
›› {{supplyCenter.scName}}
This item is not currently available on-site. Depending on your Supply Center settings you may be able to add the item to cart above else use the Order Non-Stocked Items' tab on the Supply Center home page.
Back to top


SB 202474, an inactive analog of SB202190 and SB203580, is a negative control for mitogen-activated protein kinase (MAPK) inhibition studies. This compound and its active analogues are useful for elucidating the role of p38 MAPK in affording protection against apoptotic stimuli.

Format/Formulation: Beige solid
For Research Use Only. Not for use in diagnostic procedures.


Form: Solid
Inhibitor Properties: Chemical
Inhibitor Type: Inhibitor Control, Kinase Inhibitor, Kinase Inhibitor (MAP Kinase Inhibitor)
Molecular Weight: 279.3 Da
Product Size: 1 mg
Purification: HPLC
Specific Inhibitor Target: None (Control)
Sterility: Nonsterile
Shipping Condition: Dry Ice

Contents & storage

Store in freezer (-5 to -30°C).


Manuals & protocols

Recommended products